We are pleased to share that the Rijal Lab is part of a newly funded Mississippi INBRE Project Development Grant. Ramesh Rijal serves as Co-Principal Investigator and leads Aim 3, which focuses on experimental validation of repurposed drug candidates in Mycobacterium tuberculosis using THP-1 macrophage infection models.